Literature DB >> 333455

Interaction of coagulation factor Xa with human platelets.

J P Miletich, C M Jackson, P W Majerus.   

Abstract

When human 125I-labeled Factor Xa is incubated with washed platelets, prothrombin, and Ca2+, a small amount of thrombin is formed which causes the platelet release reaction after a period of time that decreases as the Xa concentration is increased from 0.9 to 19 ng/ml. After a further lag period, the Xa binds reversibly to receptors on the platelet surface and rapid thrombin formation follows (3 units or 1 mug of thrombin formed per min per ng of Xa bound to 10(8) platelets). When platelets are treated with either htrombin (0.5 units/ml) or calcium ionophore A23187 prior to addition of Xa, binding begins immediately. Thrombin formation occurs at the platelet surface at rates that correlate with the amount of Xa bound. Dibutyryl cyclic AMP inhibits the release reaction, Xa binding, and rate of thrombin generation in parallel. The platelet Xa receptor is distinct from the previously described thrombin receptor and appears to be a protein because treatment of platelets with thrombin at 50 units/ml destroys Xa binding sites. The results suggest that specific receptors for Xa appear on the platelet surface after the release reaction occurs. The bound Xa catalyzes thrombin formation 1000-fold faster than does Xa added to reactions in which phospholipids are substituted for platelets.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 333455      PMCID: PMC431832          DOI: 10.1073/pnas.74.9.4033

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  THROMBOKINASE AS PRIME ACTIVATOR OF PROTHROMBIN: HISTORICAL PERSPECTIVES AND PRESENT STATUS.

Authors:  J H MILSTONE
Journal:  Fed Proc       Date:  1964 Jul-Aug

2.  OBSERVATIONS ON THE INTERACTION OF PHOSPHOLIPIDS AND CERTAIN CLOTTING FACTORS IN PROTHROMBIN ACTIVATOR FORMATION.

Authors:  D PAPAHADJOPOULOS; D J HANAHAN
Journal:  Biochim Biophys Acta       Date:  1964-08-19

3.  DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS.

Authors:  B J DAVIS
Journal:  Ann N Y Acad Sci       Date:  1964-12-28       Impact factor: 5.691

4.  Hypoproaccelerinemia.

Authors:  J H LEWIS; J H FERGUSON
Journal:  Blood       Date:  1955-04       Impact factor: 22.113

5.  The Stuart-Prower factor assay and its clinical significance.

Authors:  F BACHMANN; F DUCKERT; F KOLLER
Journal:  Thromb Diath Haemorrh       Date:  1958-05-01

6.  Lactic dehydrogenase activity in blood.

Authors:  F WROBLEWSKI; J S LADUE
Journal:  Proc Soc Exp Biol Med       Date:  1955-10

7.  Evidence that platelet accelerator (platelet factor 1) is adsorbed plasma proaccelerin.

Authors:  P HJORT; S I RAPAPORT; P A OWREN
Journal:  Blood       Date:  1955-11       Impact factor: 22.113

8.  Equilibrium binding of thrombin to platelets.

Authors:  B M Martin; W W Wasiewski; J W Fenton; T C Detwiler
Journal:  Biochemistry       Date:  1976-11-02       Impact factor: 3.162

Review 9.  Prothrombin structure, activation, and biosynthesis.

Authors:  J W Suttie; C M Jackson
Journal:  Physiol Rev       Date:  1977-01       Impact factor: 37.312

10.  Factor V activity of platelets: evidence for an activated factor V molecule and for a platelet activator.

Authors:  B Osterud; S I Rapaport; K K Lavine
Journal:  Blood       Date:  1977-05       Impact factor: 22.113

View more
  38 in total

1.  Thrombin generation and secretion of platelet Factor 4 during blood clotting.

Authors:  M A Shuman; S P Levine
Journal:  J Clin Invest       Date:  1978-04       Impact factor: 14.808

2.  Platelet receptor-mediated factor X activation by factor IXa. High-affinity factor IXa receptors induced by factor VIII are deficient on platelets in Scott syndrome.

Authors:  S S Ahmad; R Rawala-Sheikh; B Ashby; P N Walsh
Journal:  J Clin Invest       Date:  1989-09       Impact factor: 14.808

3.  Regulation of factor XIa activity by platelets and alpha 1-protease inhibitor.

Authors:  P N Walsh; D Sinha; F Kueppers; F S Seaman; K B Blankstein
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

4.  Identification and quantitation of platelet-associated fibronectin antigen.

Authors:  E F Plow; C Birdwell; M H Ginsberg
Journal:  J Clin Invest       Date:  1979-03       Impact factor: 14.808

5.  A coagulation pathway on bovine aortic segments leading to generation of Factor Xa and thrombin.

Authors:  D M Stern; P P Nawroth; W Kisiel; D Handley; M Drillings; J Bartos
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

6.  Inhibition of thromboxane A2 synthesis in human platelets by coagulation factor Xa.

Authors:  A K Sinha; A K Rao; J Willis; R W Colman
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

Review 7.  Current issues in thrombosis prevention with antiplatelet drugs.

Authors:  G de Gaetano; C Cerletti; E Dejana; J Vermylen
Journal:  Drugs       Date:  1986-06       Impact factor: 9.546

8.  [The importance of the plasmatic blood clotting system in the early stages of arterial thrombogenesis (author's transl)].

Authors:  H Zaugg
Journal:  Klin Wochenschr       Date:  1979-12-17

9.  Systemic lysis protects against the effects of platelet activation during coronary thrombolysis.

Authors:  D J Fitzgerald; M Hanson; G A FitzGerald
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

10.  Human coagluation factor V purification and thrombin-catalyzed activation.

Authors:  B Dahlbäck
Journal:  J Clin Invest       Date:  1980-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.